
LEXINGTON, Mass., Dec. 31 (UPI) -- A Lexington, Mass., drug company is conducting a clinical trial of a drug that may help those who stutter.
Indevus Pharmaceuticals Inc. has enrolled about half of the 120 patients they hope to include in the clinical trial. The drug company said it expects results by the middle of 2006 and if successful, a larger trial would follow, reported the Boston Globe Saturday.
Pagoclone, the experimental drug from Indevus, was a potential psychiatric drug when discovered in the 1990s. After it was licensed, drug giant Pfizer Inc. found it did not show clear improvement for panic and anxiety -- but two women who had used it stopped stuttering.
Indevus officials re-acquired the rights to pagoclone, took out a fresh patent and began the new clinical trial.
|
|
|
|
|
|
| Additional Business News Stories | |
WASHINGTON, May 23 (UPI) --
U.S. scientists said they found a way to determine the difference between oil from natural seeps and that from commercial production offshore.
|
FORT WAYNE, Ind., May 23 (UPI) --
Self-encrypting drives to protect data on mobile platforms such as laptops are to be developed for the U.S. Air Force by ITT Exelis.
|
The housing inventory rose slightly in April, which is unusual in the middle of the spring sales season. The uptick may be the result of rising seller confidence and it should ease concerns that the super tight inventory levels of the last six months...
|
What if Europe turned out to be the new Japan?
|
| Stories | Photos | People | Comments |
View Caption